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he Economic Effect of a Tertiary
ospital-Based Heart Failure Program
ouglas Gregory, PHD,* David DeNofrio, MD,† Marvin A. Konstam, MD†
oston, Massachusetts
OBJECTIVES This study was designed to determine the economic effect of a tertiary heart failure (HF)
program at an academic medical center.
BACKGROUND Most hospitals use cross-sectional financial models to analyze the economic contribution of
clinical programs for a budget period. We estimated the incremental value of a tertiary
hospital HF program on the basis of the longitudinal utilization of a sample of HF patients.
METHODS The primary data source was a sample of 82 HF patients referred for cardiac transplant
evaluation at an academic medical center during calendar years 2000 to 2001. Cumulative
recurrent rates of utilization, cost, and reimbursement for hospital services were computed as
functions of time using reliability models. The economic contribution of patients transplanted
was contrasted with those not transplanted.
RESULTS Mean hospitalizations and outpatient encounters per patient at the end of the first year of
follow-up for those transplanted were 2.1 (95% confidence interval [CI] 1.6 to 2.7) and 11.9
(95% CI 9.2 to 15.4), compared with 1.1 (95% CI 0.8 to 1.6) and 6.0 (95% CI 4.8 to 7.6),
respectively, for those not transplanted. Mean revenue and direct cost per patient were
$194,470 (95% CI $136,683 to $276,689) and $146,623 (95% CI $96,377 to $233,065),
respectively, for transplanted patients and $43,587 (95% CI $28,149 to $67,503) and $33,424
(95% CI $21,584 to $51,760), respectively, for non-transplanted patients. The point
estimates of first-year contribution margins per patient for transplanted and non-transplanted
patients were $47,847 and $10,163, respectively.
CONCLUSIONS Newly evaluated patients for cardiac transplantation at an academic medical center generated
substantial incident demands for inpatient and outpatient services over a two-year follow-up
period. The estimated contribution margin associated with these services was positive.
Hospitals without cardiac transplantation that serve high-acuity HF patients may generate
favorable long-term contribution margins, on the basis of the results for the non-transplant
group. (J Am Coll Cardiol 2005;46:660–6) © 2005 by the American College of Cardiology
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.05.042Foundation
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T
te estimated the incremental value of patients in a tertiary
ospital heart failure (HF) program on the basis of the
tilization of a sample of patients evaluated for cardiac
ransplantation at an academic medical center and followed
or two years. Using Medicare payment models for large
rban teaching hospitals and the hospital’s cost accounting
ystem, we estimated cumulative net revenue and direct cost
ccrual rates per patient over time. The contribution margin
s estimated from the difference between net revenue and
irect cost (1).
Most hospitals use budget-driven financial models to
nalyze the economic contribution of programs for a budget
eriod (month or fiscal year) (2). Budget models are
ross-sectional, aggregating the experience of all patients
onsuming a defined set of hospital services for a defined
eriod of time. Even when hospital “service lines” are
nalyzed, the analysis tends to use the same cross-sectional
ramework stratified by service line. Cross-sectional, as
From *Cardiovascular Clinical Studies and Tufts University School of Medicine,
oston, Massachusetts; and †Tufts-New England Medical Center, Department of
ardiology, and Tufts University School of Medicine, Boston, Massachusetts.(
Manuscript received November 23, 2004; revised manuscript received April 12,
005, accepted May 3, 2005.pposed to longitudinal, models will misspecify the true
nancial contribution of programs for chronic disease patients
ver time. At best, such analyses may include all services
onsumed during a budget period (i.e., fiscal year associated
ith patient events with a principal diagnosis of HF).
We calculated the incremental financial contribution
ssociated with a HF patient population. This analysis,
ncorporating both inpatient and outpatient diagnostic and
rocedural services consumed by a referral HF population, is
esigned to assess the financial impact of a chronic disease
uch as HF on a tertiary medical center.
ETHODS
atients. A sample of 82 patients evaluated for cardiac
ransplantation by Tufts-New England Medical Center’s
cademic HF program during calendar years 2000 to 2001
as followed for two subsequent years. The 82 patients
ncluded in this analysis represent all HF patients who
nderwent complete transplant evaluations during this pe-
iod and were formally presented to the institution’s Cardiac
ransplant Committee. Not all patients were listed for
ransplantation after the committee’s final recommendation
approximately 50% were listed). A HF cardiologist initially
s
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August 16, 2005:660–6 Economics of a Hospital HF Programcreened the patients referred to the center before making
he decision to initiate a complete transplant evaluation.
herefore, the patients included in the study represent a
ell-defined subgroup of the total HF population served by
he program. All hospital admissions, outpatient ancillary
ests and procedures, and clinic visits were obtained from
he hospital’s internal cost accounting system. Patient de-
ographic and clinical data were obtained from medical
ecords. Patient mortality information was obtained from
ocial Security death databases, internal medical records,
nd queries of program staff.
Descriptive statistics were used to contrast patients who
ere ultimately transplanted and those who were not
ransplanted. Chi-square and Fisher exact tests were applied
o discrete variables, and t tests for two groups were used for
ontinuous variables. Kaplan-Meier survival curves were
tted to the mortality data. Minitab (Minitab Inc., State
ollege, Pennsylvania) was used to calculate all statistical
ests. Statistical significance was defined at the 95% level.
Mean cumulative event rates per patient for inpatient
ospitalizations and outpatient encounters were estimated
or the total sample. Outpatient encounters included all
atient visits to the hospital’s clinics, emergency depart-
ent, and ancillary services. Bivariate mean cumulative
vent rates for patients transplanted versus those not trans-
lanted were also estimated. Mean cumulative event rates
er patient are expressed as a function of time from the
ndex evaluation event using non-parametric right-censored
eliability models (3). Sometimes called “conditional event
ates,” the rates are calculated over the pool of patients
urviving at each point in time an event occurs. “Marginal
vent rates adjusted for survival” were also calculated by
ultiplying the conditional event rates at each point of time
y the associated probability of survival estimated from the
aplan-Meier survival curves.
evenue and expense. Revenue for inpatient events was
stimated from the Medicare diagnosis-related group and
otal charges for each admission using 2003 Medicare
ayment methodology. Modeled revenue included allow-
nces for indirect medical education, disproportionate share
ospital payments, and cost outliers. Base payment rates
ere based on large urban teaching hospital base rates for
abor-related and non-labor-related components of cost (4).
n average wage index of 1.15 and a geographic adjustment
actor of 1.1 were used to adjust labor-related operating and
apital base payment amounts. Medicare outpatient pay-
ent rates were based on cost-to-charge ratios from the
edicare cost report applied to hospital charges (5).
Direct cost for inpatient and outpatient events was
Abbreviations and Acronyms
CI  confidence interval
HF  heart failurealculated by the hospital’s cost accounting system using sirect nursing unit, clinic, and ancillary costs and excluding
ndirect costs. Direct cost is a proxy for marginal cost used
n the health economics literature (6). Hospitalization costs
ere inflated to 2003 using the medical component of the
onsumer Price Index (7). Contribution margin was calcu-
ated as the difference between revenue and inflation-
djusted direct cost (2).
Descriptive statistics were calculated for revenue and
irect cost stratified by major clinical service (inpatient and
utpatient or transplanted and non-transplanted patients).
evenues and costs were accrued cumulatively for each
vent using statistical reliability models. Mean cumulative
osts and revenues were weighted by survival probabilities at
ach event time to calculate the mean cumulative costs and
evenues adjusted for survival.
xample. We present an example of how this methodology
ould be used to analyze the growth in a HF patient
opulation. The economic effect of adding 100 new patients
ach year for three years was estimated from the cumulative
evenue and direct cost accrual rates. Cumulative revenues
nd costs were computed for each annual cohort stratified by
ardiac transplant status. Annual cumulative contribution
argins for each year are calculated as the difference
etween cumulative revenues and direct costs. The result is a
able of cumulative revenues, costs, and contribution margins
tratified by transplant status representing the cumulative
conomic effect of adding 300 new patients over three years.
ESULTS
escriptive statistics. Table 1 presents summary statistics
f the sample of HF patients segmented into two groups:
hose with and without a transplant during the two-year
ollow-up period. Of 82 patients evaluated for cardiac
ransplantation, 27 underwent transplantation. The average
ge of the patients was 52 years, 79% were men, and 57%
ad an etiology of ischemic heart disease with no significant
ifferences between the subgroups. Survival was significantly
ifferent between the subgroups, as 95% of the transplanted
atients survived, whereas only 57% of the non-transplanted
atients survived (p  0.004) over the observation period,
hich varied from two to three years depending on when
he patient was evaluated. Consequently, the mean obser-
ation period was significantly shorter for the non-
ransplanted patients compared with transplanted patients,
2.3 months versus 31.6 months, respectively (p  0.0001).
igure 1 plots the Kaplan-Meier mortality curves for all
atients. The first-year mortality rate was 20% (95% CI 11%
o 28%). For non-transplanted patients the mortality rate
as 27% (95% CI 16% to 39%), and for transplanted
atients it was 4% (95% CI 0% to 10%). All 82 patients had
ew York Heart Association functional class III to IV HF.
Table 2 presents descriptive statistics for revenue and
irect cost stratified by inpatient and outpatient services,
ransplant and non-transplant patients, and major clinical
ervice. Outpatient revenues and direct costs include all service
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Economics of a Hospital HF Program August 16, 2005:660–6evenues and the cost of resources utilized by the patient during
he billing period. For example, an outpatient cardiology
ncounter for a transplant patient could include revenue and
osts for a transplant clinic visit, right heart catheterization,
yocardial endobiopsy, or lab tests. Consequently, cardiology
utpatient encounters for transplant patients generated $1,283
n mean revenue versus $424 for non-transplant patients. The
ost of resources required for outpatient cardiology services was
649 on average for transplanted patients versus $275 for
on-transplanted patients. All surgical subspecialties (e.g.,
eneral surgery, cardiothoracic surgery, vascular surgery, gas-
rointestinal surgery) were grouped into the surgery category.
ransplant surgery was displayed separately because of the
agnitude of revenue and cost. All medical subspecialties
xcept cardiology (e.g., general medicine, nephrology, gastro-
nterology, pulmonary, infectious disease) are included in
edicine. “Outpatient ancillary services” include outpatient
isits to the emergency department, radiology, laboratory, etc.,
ithout a clinic visit. Not surprisingly, the major difference
etween mean inpatient revenues for transplant and non-
ransplant patients was the revenue associated with cardiac
ransplantation.
Table 1. Descriptive Statistics
No Trans
(n  5
Mean observation period (months) 22.3
Age (yrs) 52.7
Gender, male 43 (78%
Mortality, survived 35 (64%
Etiology
Ischemic 30 (56%
Other 24 (41%
p Values are reported for t tests of continuous variables and c
crude mortality (number of decedents) over the observation p
patient was evaluated.igure 1. Kaplan-Meier cumulative mortality rates were estimated for the numb
cademic medical center’s heart failure program.vent rates. Figure 2 plots the cumulative mean inpatient
nd outpatient event rates for inpatient and outpatient
ervices for transplanted and non-transplanted patients. For
ransplanted and non-transplanted patients, mean cumula-
ive hospitalizations at one year were 2.4 (95% CI 1.91 to
.02]) and 1.18 (95% CI 0.85 to 1.64), respectively, whereas
utpatient encounters were 11.96 (95% CI 9.24 to 15.48)
nd 6.20 (95% CI 4.88 to 7.87), respectively.
evenue and cost. Figure 3 plots the conditional mean
umulative modeled revenues and direct costs associated
ith the inpatient and outpatient events. At one year the
verall cumulative mean net revenue per patient was
99,766 (95% CI $74,620 to $133,386) compared with
irect cost of $78,312 (95% CI $57,084 to $107,435). For
on-transplanted patients, one-year net revenue was
43,587 (95% CI $28,146 to $67,503), and direct cost was
33,424 (95% CI $21,584 to $51,760). For transplanted
atients, one-year net revenue per patient was $194,470
95% CI $136,683 to $276,689), and direct cost per patient
as $146,623 (95% CI $96,377 to $223,065). The point
stimate of revenue at every event time after evaluation was
reater than direct cost. The point estimate of cumulative
Transplant
(n  27)
All
(n  82) p Value
31.6 773 0.0001
50.7 52 0.398
22 (81%) 65 (79%) 0.729
26 (96%) 61 (74%)
0.0001
16 (59%) 46 (57%)
0.751
11 (41%) 35 (43%)
are or Fisher exact tests of discrete variables. Mortality is the
hich varied from two to three years depending on when theplant
5)
)
)
)
)
hi-squer of days after the patient was evaluated for cardiac transplantation at the
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August 16, 2005:660–6 Economics of a Hospital HF Programonditional contribution margin per patient was $21,454 at
ne year and grew to $32,000 in the second year. The point
stimates for conditional cumulative first-year contribution
argin per patient for transplanted and non-transplanted
atients were $47,847 and $10,163, respectively.
xample. Table 3 presents the results of computing the
urvival-adjusted incremental revenues, direct costs, and con-
ribution margins for each of three cohorts of 100 patients
valuated for cardiac transplantation over a 3-year period. We
ssumed a 15% transplant rate in the year patients were
valuated. After three years, cumulative revenue would total an
stimated $26 million, direct cost would be $19 million, and
ontribution margin would be approximately $7 million. The
umulative survival-adjusted revenue, direct cost, and contri-
ution margin for patients transplanted would be $11 million,
8 million, and $3 million, respectively, over the three-year
eriod. For non-transplanted patients, the cumulative survival-
djusted revenue, direct cost, and contribution margin would
igure 2. Mean cumulative hospitalizations and outpatient events per
able 2. Clinical Service Statistics
Inpatient
Variable
Clinical
Service
Non-Transplant
Patients
n Mean SEM n
et revenue Cardiology 63 $23,479 $6,785 34 $
Medicine 20 $6,863 $364 22
Surgery 23 $87,275 $20,642 16 $
Transplant 27 $2
OP ancillary
irect cost Cardiology 63 $15,404 $4,148 34
Medicine 20 $4,428 $1,159 22
Surgery 23 $65,455 $17,210 16 $
Transplant 27 $1
OP ancillary
edicine comprises all medical subspecialties except cardiology. Surgery comprises g
OP ancillary  emergency room visits and general non-cardiology ancillary servicon-parametric reliability models and are conditional on survival. Inpatient events
nd non-cardiovascular services. Outpatient events include patient encounters fe $15 million, $11 million, and $4 million, respectively, over
he three-year period.
ISCUSSION
his paper has presented estimates of the longitudinal eco-
omic effect of patients evaluated for cardiac transplantation in
HF program at an academic medical center. Although the
pecific estimates are applicable to similar settings, the meth-
dology is applicable to evaluating any hospital program for
atients with a progressive chronic disease.
Most hospitals use budget- and cost-center-driven finan-
ial models to analyze the economic contribution of pro-
rams such as those for HF patients. Even when hospital
service lines” are analyzed, the analysis tends to use the
ame framework stratified by service line. Such models may
isspecify the financial contribution of programs for
hronic disease patients. For example, a one-year analysis of
nt stratified by transplant status were estimated from right-censored
Outpatient
plant
ents
Non-Transplant
Patients
Transplant
Patients
SEM n Mean SEM n Mean SEM
9 $2,804 456 $424 $36 603 $1,283 $55
0 $1,011 137 $155 $19 223 $266 $33
1 $11,350 30 $1,315 $971 90 $463 $80
7 $27,798
26 $278 $74 11 $297 $54
6 $1,757 456 $275 $23 603 $649 $27
7 $677 137 $126 $12 223 $159 $15
5 $9,903 30 $1,104 $793 90 $241 $37
3 $26,590
26 $167 $27 11 $198 $22
surgery and all surgical subspecialties.
h as radiology, laboratory, and so on.patieTrans
Pati
Mean
12,92
$7,28
41,86
11,71
$9,01
$3,95
33,26
49,91included all hospitalizations for heart failure, other cardiovascular services,
or the hospital’s clinic, ancillary, or emergency services.
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Economics of a Hospital HF Program August 16, 2005:660–6he cost centers associated with a HF program may focus on
he revenues and expenses associated with a HF outpatient
linic or a dedicated inpatient unit. A service line analysis
ay focus exclusively on HF hospitalizations such as
iagnosis-related group 127, “Heart Failure and Shock.” At
est, such analyses may include all services consumed during
budget period (i.e., fiscal year) associated with patient
vents with a principal diagnosis of HF. What they typically
ail to do is to track a sample of new HF patients over time
o calculate the incremental economic contribution of the
F patient population. Such an analysis will demonstrate
he multitude of inpatient and outpatient, diagnostic, med-
cal, and procedural services required by chronically ill HF
atients. The bundle of services required by these patients is
ot limited to the HF program or to the departments of
ardiology or cardiothoracic surgery. By providing high-
uality HF programs that meet the multiple interdiscipli-
ary service needs of this patient population, hospitals may
mprove both the quality of care and their bottom line by
ttracting additional patients with HF.
Hospitals have an obligation to meet demonstrated stan-
ards for high-quality care, such as the evolving consensus
or HF care, irrespective of economics. As mentioned,
igure 3. Net revenue was modeled by 2003 Medicare national teaching
elative wages, disproportionate share hospital allowance, and capital and
omponent of the Consumer Price Index. Mean cumulative accrual rates of
rom right-censored non-parametric reliability models and are conditionalowever, short-term decision making with respect to such crograms is a frequent consequence of the current emphasis
n hospital budgets and reimbursement.
The analysis presented here estimated the mean rates of
tilization, net revenue, and cost accumulation over time
ssociated with a population of HF patients with high acuity
nd high likelihood of cardiac transplantation. Thus, the
pecific findings may be most applicable to similar settings
ith similar patient populations, for example, academic
edical centers with a cardiac transplantation service. The
ethodology presented here for estimating the economic
ontribution of HF programs, however, is applicable to all
ettings. Moreover, the non-transplant group may be rep-
esentative of HF patient populations served by many
ommunity hospitals. The first-year mortality rate of 27%
nd survival-adjusted first-year expected hospitalization rate
f 0.96 hospitalizations per patient may be characteristic of
ommunity hospitals with HF programs that attract high-
cuity patients. In this case, the non-transplant economic
nalysis in Table 2 may be indicative of the economic impli-
ations of adding incremental HF patients. The percentage
ontribution margins (contribution margin divided by revenue)
or transplant and non-transplant patients were comparable at
5% and 23%, respectively. In addition, the total economic
ital rates, including adjustments for indirect medical education, regional
rating cost allowances. Direct cost was inflated to 2003 by the medical
ue and direct cost per patient stratified by transplant status were estimated
rvival.hosp
ope
reven
on suontribution of non-transplant patients in Table 2 was greater
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August 16, 2005:660–6 Economics of a Hospital HF Programor non-transplant patients (given the greater incidence of
on-transplant patients): $4 million versus $3 million. Hospi-
als without cardiac transplantation but with strong HF pro-
rams should be encouraged by these results.
Revenues were higher for transplant than for non-transplant
atients for two reasons. First, the rates of hospitalization and
utpatient encounters per patient for transplant patients are
bout double the corresponding rates for non-transplant pa-
ients. Second, the percentage of hospitalizations for surgical
rocedures is higher for the transplant group (55%) than for
he non-transplant group (42%), and surgical procedures result
n higher contribution margins (23.3% on average) than
edical hospitalizations (16.6% on average). These differences
re attributable in part to the greater incidence of diagnostic
atheterizations and clinic visits required for monitoring of
ransplant patients. Moreover, hospitalizations of after-
ransplant patients for toxicity due to immunosuppressive
herapy and for after (transplant) surgical complications also
enerate greater utilization of both inpatient and outpatient
esources.
This analysis is limited by the small sample size and high
cuity of the patient population sampled. In addition, the
se of Medicare payment models to estimated revenue may
ot be representative of local hospital reimbursement. Fi-
ally, the analysis is limited to hospitalization and outpa-
ient events at the study hospital. In this instance, we believe
hat patients evaluated for cardiac transplantation in this
nstitution were likely to receive most, but not necessarily
ll, of their care at the study hospital.
onclusions. Newly evaluated patients for cardiac trans-
lantation at an academic medical center were shown to
enerate substantial incident demands for inpatient and
utpatient services over a two-year follow-up period. For
xample, mean inpatient Medicare revenue per patient
ssociated with non-transplanted patients is over $40,000 in
he first year and nearly $200,000 for transplanted patients.
hese services appeared to generate, on average, a positive
ontribution margin for the hospital. Hospitals without
ardiac transplantation that serve high-acuity HF patients
ay generate favorable long-term contribution margins on
he basis of results for the non-transplant group. Hospital
rograms that address the multiple interdisciplinary needs
f patients with HF may attract additional patients, with
onsequent beneficial economic effects for the hospital.
ocused multidisciplinary programs directed toward pa-
ients with HF are needed to meet the complex needs of
hese patients and optimize their care and clinical outcomes.
ospitals should be encouraged by our analyses that, far
rom being a drain on institutional resources, such programs
hould actually generate positive margins for the institution.
n order to properly gauge the financial impact of such
rograms, it is essential to augment traditional budget
nalyses of clinical programs with strategic longitudinal
nalyses of the type presented here. Ta
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